These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38703073)

  • 1. Colorectal Cancer in Inflammatory Bowel Disease: A Review of the Role of Gut Microbiota and Bacterial Biofilms in Disease Pathogenesis.
    Muñiz Pedrogo DA; Sears CL; Melia JMP
    J Crohns Colitis; 2024 Oct; 18(10):1713-1725. PubMed ID: 38703073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer.
    Lavelle A; Nancey S; Reimund JM; Laharie D; Marteau P; Treton X; Allez M; Roblin X; Malamut G; Oeuvray C; Rolhion N; Dray X; Rainteau D; Lamaziere A; Gauliard E; Kirchgesner J; Beaugerie L; Seksik P; Peyrin-Biroulet L; Sokol H
    Gut Microbes; 2022; 14(1):2078620. PubMed ID: 35638103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More on the interplay between gut microbiota, autophagy, and inflammatory bowel disease is needed.
    Subramanian A; Jahabardeen A; Thamaraikani T; Vellapandian C
    World J Gastroenterol; 2024 Jul; 30(27):3356-3360. PubMed ID: 39086745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease.
    Zhang L; Ocansey DKW; Liu L; Olovo CV; Zhang X; Qian H; Xu W; Mao F
    Biomed Pharmacother; 2021 Aug; 140():111752. PubMed ID: 34044275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER; Chang DK
    World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies.
    Fantini MC; Guadagni I
    Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesalamine protects against colorectal cancer in inflammatory bowel disease.
    Tang J; Sharif O; Pai C; Silverman AL
    Dig Dis Sci; 2010 Jun; 55(6):1696-703. PubMed ID: 19705280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the interactions between the gut microbiota and the inflammatory response to ulcerative colitis in a mouse model of dextran sodium sulfate and possible mechanisms of action for treatment with PE&AFWE.
    Fu Q; Ma X; Li S; Shi M; Song T; Cui J
    Animal Model Exp Med; 2024 Apr; 7(2):83-97. PubMed ID: 38664929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.